Active substanceAmbroxolAmbroxol
Similar drugsTo uncover
  • Ambroben
    solution d / inhal. inwards 
  • Ambroben
    syrup inwards 
  • Ambroben
    pills inwards 
  • Ambroben
    solution in / in 
  • Ambroben
    capsules inwards 
  • Ambroghexal®
    syrup inwards 
    Sandoz d.     Slovenia
  • Ambroghexal®
    solution d / inhal. inwards 
    Sandoz d.     Slovenia
  • Ambroghexal®
    pills inwards 
    Sandoz d.     Slovenia
  • AmbroHEXAL®
    capsules inwards 
    HEXAL AG     Germany
  • Ambroxol
    syrup inwards 
    ECOLAB, CJSC     Russia
  • Ambroxol
    solution d / inhal. inwards 
    ATOLL, LLC     Russia
  • Ambroxol
    pills inwards 
  • Ambroxol
    syrup inwards 
  • Ambroxol
    syrup inwards 
  • Ambroxol
    syrup inwards 
    ATOLL, LLC     Russia
  • Ambroxol
    pills inwards 
  • Ambroxol
    pills inwards 
    VERTEKS, AO     Russia
  • Ambroxol
    pills inwards 
    OZONE, LLC     Russia
  • Ambroxol
    pills inwards 
  • Ambroxol
    syrup inwards 
    ROSLEKS PHARM, LLC     Russia
  • Ambroxol
    pills inwards 
  • Ambroxol
    pills inwards 
    LEKHIM-KHARKOV, CJSC     Ukraine
  • Ambroxol
    pills inwards 
    NIZHFARM, JSC     Russia
  • Ambroxol
    syrup inwards 
    FARMTECHNOLOGIYA, LLC     Republic of Belarus
  • Ambroxol
    pills inwards 
    ALSI Pharma, ZAO     Russia
  • Ambroxol
    solution d / inhal. inwards 
    UPDATE OF PFC, CJSC     Russia
  • Ambroxol
    pills inwards 
    UPDATE OF PFC, CJSC     Russia
  • Ambroxol
    syrup inwards 
    VERTEKS, AO     Russia
  • Ambroxol
    pills inwards 
    AVEKSIMA, JSC     Russia
  • Ambroxol
    solution inwards 
  • Ambroxol
    syrup inwards 
    VERTEKS, AO     Russia
  • Ambroxol Vramed
    syrup inwards 
    Sopharma, AO     Bulgaria
  • Ambroxol retard
    capsules inwards 
  • Ambroxol-Vial
    syrup inwards 
    VIAL, LLC     Russia
  • Ambroxol-3T
    syrup inwards 
  • Ambroxol Richter
    syrup inwards 
  • Ambroxol Richter
    pills inwards 
  • Ambroxol-SOLOfarm
    solution d / inhal. inwards 
    GROTEKS, LLC     Russia
  • Ambroxol-Hemofarm
    syrup inwards 
    Hemofarm AD     Serbia
  • Ambroxol-Hemofarm
    pills inwards 
    Hemofarm AD     Serbia
  • Ambrolore
    syrup inwards 
  • Ambrosan®
    solution inwards 
    PRO.MED.CS Prague as.     Czech Republic
  • Ambrosan®
    pills inwards 
    PRO.MED.CS Prague as.     Czech Republic
  • Bronhoxol
    pills inwards 
  • Bronhoxil®
    solution inwards 
  • Bronchorus®
    syrup inwards 
    SYNTHESIS, OJSC     Russia
  • Bronchorus®
    pills inwards 
    SYNTHESIS, OJSC     Russia
  • Wicks Active AmbroMed
    syrup inwards 
  • Lazolvan®
    lozenges inwards 
  • Lazolvan®
    solution d / inhal. inwards 
  • Lazolvan®
    syrup inwards 
  • Lazolvan®
    pills inwards 
  • Lazolvan® Max
    capsules inwards 
  • Lazognin®
    pills inwards 
  • Medox®
    syrup inwards 
    Zentiva c.s.     Czech Republic
  • Medox®
    pills inwards 
    Zentiva as.     The Slovak Republic
  • Neo-Bronchol®
    pills locally inwards 
    Divafarma GmbH     Germany
  • ORVIS® Bronho
    solution d / inhal. inwards 
    EVALAR, CJSC     Russia
  • Remebroks
    syrup inwards 
    REMEDIYA, LLC     Russia
  • Suprima-kof
    pills inwards 
  • Thoraxol Solidshn Tablets
    pills inwards 
    ATOLL, LLC     Russia
  • Flavamed®
    pills inwards 
  • Flavamed®
    solution inwards 
  • Flavamed® max
    pills inwards 
    Berlin-Chemie, AG     Germany
  • Halixol®
    pills inwards 
  • Halixol®
    syrup inwards 
  • Dosage form: & nbspsyrup
    Composition:In 10 ml of syrup contains active substance ambroksol a hydrochloride - 30 mg; auxiliary ingredients: sorbitol, povidone (K-90), citric acid monohydrate, sodium cyclamate, strawberry flavor 22754, banana flavor 270650, sodium benzoate, sodium citrate, purified water.
    Description:

    Colorless or pale yellow color, clear liquid without sediment, with a characteristic odor.

    Pharmacotherapeutic group:Expectorant, mucolytic agent
    ATX: & nbsp

    R.05.C.B.06   Ambroxol

    Pharmacodynamics:

    Ambroxol is an active metabolite of bromhexine, belongs to the benzylamine group of mucolytic substances.

    It dilutes sputum by increasing the production and increasing activity of hydrolytic enzymes that break down the bonds between mucopolysaccharides of sputum.

    Improves the rheological properties of sputum, reducing its viscosity and adhesive properties, by stimulating serous cells of the glands of the bronchial mucosa and normalizing the ratio of mucous and serous sputum components. Increases mucociliary transport, increasing the motor activity of the ciliated epithelium. Does not cause excessive secretion, reduces spastic hyperreactivity of the bronchi. Contributes to the production of surfactant.

    The effect develops 30 minutes after taking the drug.

    Pharmacokinetics:

    Almost completely absorbed in the gastrointestinal tract. Approximately 80% binds to blood plasma proteins. It is subject to active metabolism of the "first passage" in the liver. Bioavailability after oral administration is approximately 60%. The time to reach the maximum concentration is 2 hours.

    Approximately 90% of the dose taken is excreted in the urine in the form of glucuronide conjugate ambroxol or oxidized products of its metabolism.The half-life period is about 7 hours, it increases with severe renal failure, it does not change if liver function is impaired.

    Penetrates through the placental barrier. Its concentration in the fetus is 2-4 times higher than that of the mother. It is found in breast milk and cerebrospinal fluid.

    Indications:

    Acute and chronic diseases of the respiratory system, accompanied by the formation of viscous sputum: bronchitis, bronchial asthma, chronic obstructive pulmonary disease, pneumonia, bronchiectatic disease.

    Inflammatory diseases of ENT organs (sinusitis, otitis), in which liquefaction of mucus is necessary.

    Contraindications:

    Hypersensitivity to ambroxol or bromhexine.

    Ulcerative lesion of the gastrointestinal tract.

    Pregnancy (I term)

    Carefully:Severe kidney failure.
    Pregnancy and lactation:The drug is contraindicated for admission in the first trimester of pregnancy; the drug is excreted in breast milk, therefore, when taking the drug during lactation, the question of stopping breastfeeding should be resolved.
    Dosing and Administration:

    Inside, after eating and squeezed a lot of liquid.The syrup can be taken with the help of a measuring cap, which is supplied with the drug. Abundant fluid intake contributes to liquefaction of mucus during treatment with Chaliixol.

    Adults and children over 12 years of age: the usual daily dose in the first 2-3 days of treatment: 10 ml of syrup 3 times a day, and in the following days - 10 ml of syrup 2 times a day or 5 ml of syrup 3 times a day. In severe cases, the dose is not reduced throughout the course of treatment.

    Children under 2 years: 2.5 ml of syrup 2 times a day.

    2-5 years: 2.5 ml of syrup 3 times a day.

    5-12 years old: 5 ml of syrup 2-3 times a day.

    In severe renal failure, lower doses should be given or the intervals between doses should be increased.

    When taking Chaliksol for more than 4-5 days, a doctor's consultation is recommended.

    Side effects:

    Halixol, as a rule, is well tolerated. Rarely, the following side effects can be observed: weakness, headache, diarrhea, constipation, dry mouth and respiratory tract, rhinorrhea, dysuria, gastralgia, nausea, vomiting, exanthema, urticaria. Very severe acute anaphylactic reactions were rarely reported, but their causal relationship with ambroxol was not established.

    Overdose:

    Symptoms: nausea, vomiting, diarrhea, indigestion.

    Treatment: cause vomiting, then prescribe a drink (milk or tea), taking fat-containing products. Gastric lavage is recommended within 1-2 hours after taking the drug. You should constantly monitor the function of the cardiovascular system.

    Interaction:

    Antitussive drugs (incl. codeine) may make it difficult to isolate phlegm diluted with ambroxol.

    Halixol promotes the penetration of certain antibiotics into the bronchial secret (amoxicillin, cefuroxime, erythromycin, doxycycline and etc.).

    Special instructions:

    It should not be prescribed with antitussive drugs - difficulty in sputum production. The use of the drug in patients with impaired bronchial motor function or abundant sputum with low viscosity requires caution because of the danger of stagnation of bronchial secretions.

    The syrup contains nonspecific sweeteners, sorbitol and sodium cyclamate, so patients with diabetes can use this drug, but the content of sorbitol (1.2 grams per 5 ml of syrup) should be taken into account by patients suffering from diabetes.

    The drug does not contain alcohol.

    Form release / dosage:Syrup.
    Packaging:

    For 100 ml of syrup in a bottle of brown glass with a white aluminum lid with the control of the first autopsy. 1 bottle together with the instruction for use and a measuring cup are packed in a cardboard box.

    Storage conditions:

    At a temperature of 15-25 ° C, out of reach of children.

    Shelf life:

    5 years. The open vial is stored for 4 weeks.

    Do not use the drug after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N016005 / 02
    Date of registration:10.08.2009
    The owner of the registration certificate:EGIS ZAO Pharmaceutical Plant EGIS ZAO Pharmaceutical Plant Hungary
    Manufacturer: & nbsp
    Representation: & nbspEGIS ZAO Pharmaceutical Plant EGIS ZAO Pharmaceutical Plant Hungary
    Information update date: & nbsp24.09.2015
    Illustrated instructions
      Instructions
      Up